ROSYY yields 198.02% · PFE yields 6.13%● Live data
📍 ROSYY pulled ahead of the other in Year 1
Combined, ROSYY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ROSYY + PFE for your $10,000?
Public Joint Stock Company Rostelecom provides digital services and solutions in Russia. The company provides Rostelecom Key, an ecosystem of services for households that offers smart intercom, smart gate bar, and smart meter solutions, as well as integrated video surveillance platform; Pay TV; Wink, a digital video services; and smart home services. It also offers antivirus solutions; Wi-Fi 2.0 platform; corporate TV's; virtual BX; toll-free calling 8-800; Game-RT-X routers; IT solutions for municipal solid waste management; video surveillance services; and VDI/VDC and cyber security services. In addition, the company offers NVIDIA, a cloud gaming service; Kapsula, a smart speaker; submarine cables; R&D; maintenance and recreational; engineering design; data and data storage; telecommunication and IT consulting; and engages in leasing of equipment, communication equipment manufacturing, retail, real estate, and venture and pension fund activities. Further, it provides solutions for electronic government, cybersecurity, data center and cloud-based services, biometrics, healthcare, education, house maintenance, and utility services. The company was incorporated in 1993 and is headquartered in Moscow, Russia.
Full ROSYY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.